Pharma News Anupam Rasayan acquisition: Is it a smart move for growth? September 29, 2026 Kenneth Bennett Anupam Rasayan acquisition has raised eyebrows in the pharma sector. Discover the implications of this ₹1,750-cr deal with Bliss GVS Pharma.
News How Online Healthcare Systems Improve the Patient-Provider Communication Process September 28, 2026 Kenneth Bennett Communication central. Discover how communication is central to patient-provider relationships in telehealth.
pharma Ono Pharmaceutical Excopri Approval: A Clear Positive Change September 26, 2026 Kenneth Bennett Ono Pharmaceutical Excopri approval could change the company's narrative significantly.
News GHK-Cu: Understanding the Scientific Interest Behind This Copper Peptide September 23, 2026 Kenneth Bennett Explore GHK-Cu and its scientific significance in skin biology and peptide research.
pharma Oncology portfolio approvals: Proven benefits for patients September 22, 2026 Kenneth Bennett Oncology portfolio approvals are crucial for advancing treatment options in Azerbaijan.
News Dr. Sergio Sokol: Connecting Medical Training With Modern Cardiovascular Practice September 18, 2026 Kenneth Bennett Explore Dr. Sergio Sokol's journey in building broad medical knowledge in modern cardiovascular practice.
News Dr. Mark Armitage and the Evolving Role of Family Medicine September 18, 2026 Kenneth Bennett Explore Dr. Mark Armitage's approach to family medicine, focusing on prevention and personalized patient care.
News TMT India stake acquisition: A Smart Move for MDK Properties September 17, 2026 Kenneth Bennett TMT India stake acquisition has been disclosed by MDK Properties, showcasing their strategic investment in the pharma sector.
pharma Eli Lilly FDA approvals: Are They the Right Growth Strategy? September 9, 2026 Kenneth Bennett Eli Lilly FDA approvals could be a game changer for growth. Discover the potential impact on the company's future.
pharma Neurotech cannabinoid approval: A Clear Path to Success September 9, 2026 Kenneth Bennett Neurotech cannabinoid approval could lead to significant advancements in the pharmaceutical industry. Discover the potential impact now.
